Growth
Fastest-growing Healthcare companies by revenue
Healthcare companies worth over $1 billion ranked by revenue growth over the last year.
Top of the list: Liquidia Technologies (LQDA) +1842.7%; Crispr Therapeutics AG (CRSP) +1041.4%; Nuvation Bio (NUVB) +555.6%.
The median revenue growth across these 50 companies is +66.3%.
| # | Company | Revenue growth | Revenue growth (5y/yr) | Operating margin | P/S | Market cap |
|---|---|---|---|---|---|---|
| 1 | Liquidia Technologies IncLQDA | +1842.7% | +192.5% | 37.4% | 5.79x | $2.6B |
| 2 | Crispr Therapeutics AGCRSP | +1041.4% | +37.3% | -3990.0% | 358.4x | $4.8B |
| 3 | Nuvation Bio IncNUVB | +555.6% | — | -81.0% | 9.45x | $1.6B |
| 4 | Kymera Therapeutics IncKYMR | +466.4% | +2.9% | -333.5% | 83.0x | $8.7B |
| 5 | Legend Biotech CorpLEGN | +421.9% | +68.8% | — | 1.92x | $3.2B |
| 6 | Ascentage Pharma Group InternationalAAPG | +341.8% | — | — | 2.19x | $1.3B |
| 7 | Lakefront Biotherapeutics NVLKFT | +303.5% | +18.4% | 26.5% | 1.80x | $1.9B |
| 8 | Insmed IncINSM | +296.1% | +29.8% | -73.9% | 17.3x | $19.6B |
| 9 | Viridian Therapeutics IncVRDN | +278.7% | +132.2% | -569.7% | 29.4x | $2.1B |
| 10 | Agios PharmAGIO | +259.2% | — | -466.8% | 18.8x | $1.9B |
| 11 | UroGen Pharma LtdURGN | +199.2% | +56.2% | -35.3% | 8.98x | $1.7B |
| 12 | Mesoblast LtdMESO | +191.4% | -11.8% | — | 107.2x | $1.8B |
| 13 | Arrowhead Pharmaceuticals IncARWR | +171.0% | +56.6% | -33.8% | 13.0x | $8.7B |
| 14 | Uniqure NVQURE | +127.3% | -15.6% | -1059.7% | 66.4x | $1.2B |
| 15 | Sonida Senior Living IncSNDA | +122.0% | -0.1% | -13.6% | 3.01x | $1.6B |
| 16 | BridgeBio Pharma IncBBIO | +120.4% | +127.4% | -69.8% | 17.3x | $12.3B |
| 17 | Waters CorporationWAT | +113.3% | +6.0% | 7.1% | 9.17x | $42.6B |
| 18 | PTC Therapeutics IncPTCT | +101.5% | +35.4% | 12.4% | 5.09x | $5.1B |
| 19 | Immunitybio IncIBRX | +93.9% | +184.8% | -151.9% | 63.2x | $10.5B |
| 20 | Syndax Pharmaceuticals IncSNDX | +91.8% | +157.7% | -77.0% | 5.76x | $1.5B |
| 21 | argenx NV ADRARGX | +88.6% | +152.7% | 24.8% | 11.9x | $50.6B |
| 22 | Madrigal Pharmaceuticals IncMDGL | +71.2% | — | -25.1% | 8.36x | $10.7B |
| 23 | TG Therapeutics IncTGTX | +70.3% | +426.7% | 17.1% | 9.37x | $7.5B |
| 24 | Tarsus Pharmaceuticals IncTARS | +69.4% | — | -8.0% | 4.92x | $3.0B |
| 25 | Alnylam Pharmaceuticals IncALNY | +66.9% | +49.8% | — | 7.13x | $30.6B |
| 26 | Iovance Biotherapeutics IncIOVA | +65.7% | — | -92.7% | 19.8x | $6.4B |
| 27 | BillionToOne, Inc. Class A Common StockBLLN | +64.4% | — | 10.9% | 10.8x | $4.3B |
| 28 | Kestra Medical Technologies, Ltd. Common StockKMTS | +59.9% | — | -134.5% | 14.3x | $1.5B |
| 29 | Arcutis Biotherapeutics IncARQT | +59.3% | — | 7.4% | 7.07x | $3.3B |
| 30 | Cronos Group IncCRON | +58.4% | +25.7% | -1.4% | 6.49x | $1.2B |
| 31 | Telix Pharmaceuticals LimitedTLX | +55.6% | — | 3.7% | 4.62x | $3.7B |
| 32 | Clover Health Investments CorpCLOV | +55.6% | +23.4% | -0.74% | 1.00x | $2.5B |
| 33 | Kiniksa Pharmaceuticals LtdKNSA | +55.5% | — | 12.4% | 7.47x | $5.6B |
| 34 | Hinge Health, Inc.HNGE | +53.0% | — | 13.0% | 11.2x | $8.1B |
| 35 | CareDx IncCDNA | +52.2% | +14.6% | 23.6% | 7.09x | $3.2B |
| 36 | Glaukos CorpGKOS | +49.5% | +17.7% | -31.6% | 16.2x | $9.9B |
| 37 | Astrana Health IncASTH | +48.5% | +35.9% | 2.6% | 0.47x | $1.8B |
| 38 | Travere Therapeutics IncTVTX | +48.2% | +19.9% | -6.8% | 7.78x | $4.6B |
| 39 | Eli Lilly and CompanyLLY | +47.7% | +21.6% | — | 13.5x | $1.08T |
| 40 | Halozyme Therapeutics IncHALO | +47.7% | +39.2% | 35.9% | 7.55x | $12.6B |
| 41 | Heartflow, Inc. Common StockHTFL | +47.6% | — | -37.8% | 16.6x | $3.5B |
| 42 | Rhythm Pharmaceuticals IncRYTM | +46.9% | — | -83.6% | 24.7x | $5.9B |
| 43 | Axsome Therapeutics IncAXSM | +45.5% | — | -24.0% | 10.9x | $8.4B |
| 44 | Caris Life Sciences, Inc. Common StockCAI | +45.4% | — | 15.5% | 8.98x | $8.9B |
| 45 | Guardant Health IncGH | +44.3% | +27.9% | -39.8% | 18.7x | $22.1B |
| 46 | Ascendis Pharma ASASND | +42.3% | +153.0% | -18.9% | 16.0x | $13.8B |
| 47 | Neurocrine Biosciences IncNBIX | +39.5% | +22.3% | 23.6% | 4.14x | $14.0B |
| 48 | Butterfly Network IncBFLY | +39.5% | +16.1% | -70.8% | 18.8x | $2.1B |
| 49 | Hims Hers Health IncHIMS | +38.2% | +73.6% | -6.0% | 2.65x | $6.8B |
| 50 | Mirum Pharmaceuticals IncMIRM | +37.9% | — | -134.9% | 7.54x | $4.7B |
Ranked from each company's latest price and reported results. Companies need a page on Investingly (SEC statements on file). Open any company for its reverse DCF, insider buying and 13F holders.
Other sectors
Fastest-growing companies by revenue (all sectors)Fastest-growing Technology companies by revenueFastest-growing Financial Services companies by revenueFastest-growing Communication Services companies by revenueFastest-growing Consumer Cyclical companies by revenueFastest-growing Industrials companies by revenueFastest-growing Energy companies by revenueFastest-growing Consumer Defensive companies by revenueFastest-growing Basic Materials companies by revenueFastest-growing Utilities companies by revenueFastest-growing Real Estate companies by revenue
Questions
Which company ranks first on the fastest-growing healthcare companies by revenue list?
Liquidia Technologies (LQDA), with a revenue growth of +1842.7%, as of October 12, 2026.
How is this list built?
US companies worth over $1 billion ranked by revenue growth over the last year. It shows the top 50 and is rebuilt every day.
Prices and ratios as of Oct 11, 2026. Statements from SEC filings. Information only, not investment advice.